Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections

Journal of Medical Virology

Volumn 80, Issue 8, 2008, Pages 1405-1414

  Görzer, Irene ^a   Kerschner, Heidrun ^a   Jaksch, Peter ^b   Bauer, Claudia ^a   Seebacher, Gernot ^b   Klepetko, Walter ^b   Puchhammer Stöckl, Elisabeth ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

gB genotypes; Genotype specific quantitative PCR; gH genotypes; Human cytomegalovirus; Lung transplantation

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN H; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; VALGANCICLOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; GENOTYPE; GRAFT RECIPIENT; HUMAN; LUNG; LUNG LAVAGE; LUNG TRANSPLANTATION; MIXED INFECTION; MOLECULAR DYNAMICS; POSTOPERATIVE PERIOD; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADOLESCENT; ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GENOTYPE; HUMANS; LUNG TRANSPLANTATION; POLYMERASE CHAIN REACTION; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

HUMAN HERPESVIRUS 5;

EID: 46049084172     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21225     Document Type: Article

References (30)

1. Aquino VH, Figueiredo LT. 2000. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 61:138-142.
2. Balthesen M, Messerle M, Reddehase MJ. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 67:5360-5366.
3. Bauer CC, Jaksch P, Aberle SW, Haber H, Lang G, Klepetko W, Hofmann H, Puchhammer-Stöckl E. 2007. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324-328.
4. Boeckh M, Nichols WG. 2003. Immunosuppressive effects of beta-herpesviruses. Herpes 10:12-16.
5. Chou SW, Dennison KM. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163:1229-1234.
6. Chou S. 1992. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 166:604-607.
7. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W, Herbein G. 2004. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39:155-161.
8. Compton T. 2004. Receptors and immune sensors: The complex entry path of human cytomegalovirus. Trends Cell Biol 14:5-8.
9. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GW, Davison AJ. 2004. Genetic content of wild-type human cytomegalovirus. J Gen Virol 85:1301-1312.
10. Erice A. 1999. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 12:286-297.
11. Gandhi MK, Khanna R. 2004. Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4:725-738.
12. Gerna G, Lilleri D. 2006. Monitoring transplant patients for human cytomegalovirus: Diagnostic update. Herpes 13:4-11.
13. Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD. 1988. Symptomatic cytomegalovirus infection in seropositive kidney recipients: Reinfection with donor virus rather than reactivation of recipient virus. Lancet 2:132-135.
14. Humar A, Kumar D, Gilbert C, Boivin G. 2003. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 188:581-584.
15. Mach M. 2006. Antibody-mediated neutralization of infectivity. In: Reddehase MJ, editor. Cytomegaloviruses molecular biology and immunology. Llymoudham, Norfolk, UK: Caister Academic Press, pp 265-283.
16. Meyer-König U, Ebert K, Schrage B, Pollak S, Hufert FT. 1998. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352:1280-1281.
17. Patel R, Paya CV. 1997. Infections in solid-organ transplant recipients. Clin Microbiol Rev 10:86-124.
18. Puchhammer-Stöckl E, Görzer I, Zoufaly A, Jaksch P, Bauer CC, Klepetko W, Popow-Kraupp T. 2006. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 81:187-194.
19. Rasmussen L, Geissler A, Winters M. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 187:809-819.
20. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185-193.
21. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102:4140-4145.
22. Retiere C, Lesimple B, Lepelletier D, Bignon JD, Hallet MM, ImbertMarcille BM. 2003. Association of glycoprotein B and immediate early-1 genotypes with human leukocyte antigen alleles in renal transplant recipients with cytomegalovirus infection. Transplantation 75:161-165.
23. Sawtell NM, Poon DK, Tansky CS, Thompson RL. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 72:5343-5350.
24. Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF. 2006. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. J Immunol 176:2625-2634.
25. Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763-1779.
26. Singh N. 2006. Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies. J Clin Virol 35:474-477.
27. Smyth RL, Sinclair J, Scott JP, Gray JJ, Higenbottam TW, Wreghitt TG, Wallwork J, Borysiewicz LK. 1991. Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation 52:480-482.
28. Soderberg-Naucler C. 2006. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit Rev Immunol 26:231-264.
29. Spear PG, Longnecker R. 2003. Herpesvirus entry: An update. J Virol 77:10179-10185.
30. Zamora MR. 2004. Cytomegalovirus and lung transplantation. Am J Transplant 4:1219-1226.